Novartis Ag (NVS) Operating Leases (2018 - 2025)
Historic Operating Leases for Novartis Ag (NVS) over the last 8 years, with Q4 2025 value amounting to $1.9 billion.
- Novartis Ag's Operating Leases rose 418510.64% to $1.9 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $1.9 billion, marking a year-over-year increase of 418510.64%. This contributed to the annual value of $1.9 billion for FY2025, which is 418510.64% up from last year.
- Latest data reveals that Novartis Ag reported Operating Leases of $1.9 billion as of Q4 2025, which was up 418510.64% from -$1.8 billion recorded in Q1 2025.
- Over the past 5 years, Novartis Ag's Operating Leases peaked at $2.7 billion during Q1 2023, and registered a low of -$2.0 billion during Q1 2022.
- In the last 5 years, Novartis Ag's Operating Leases had a median value of $146.0 million in 2023 and averaged $593.1 million.
- Examining YoY changes over the last 5 years, Novartis Ag's Operating Leases showed a top increase of 418510.64% in 2025 and a maximum decrease of 17080.5% in 2025.
- Quarter analysis of 5 years shows Novartis Ag's Operating Leases stood at $1.9 billion in 2021, then plummeted by 98.79% to $23.0 million in 2022, then skyrocketed by 534.78% to $146.0 million in 2023, then crashed by 132.19% to -$47.0 million in 2024, then skyrocketed by 4185.11% to $1.9 billion in 2025.
- Its Operating Leases was $1.9 billion in Q4 2025, compared to -$1.8 billion in Q1 2025 and -$47.0 million in Q4 2024.